Loading…

Impact of Oxytocin on the neural correlates of fearful face processing in PTSD related to childhood Trauma

Background: Posttraumatic stress disorder (PTSD) related to exposure to abuse and neglect during childhood is associated with particularly severe and persistent deleterious outcomes. Amygdala hyperreactivity has been observed in childhood trauma survivors and implicated in symptoms of PTSD. Objectiv...

Full description

Saved in:
Bibliographic Details
Published in:European journal of psychotraumatology 2019-01, Vol.10 (1), p.1606626
Main Authors: Flanagan, Julianne C., Sippel, Lauren M., Santa Maria, Megan M. Moran, Hartwell, Karen J., Brady, Kathleen T., Joseph, Jane E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Posttraumatic stress disorder (PTSD) related to exposure to abuse and neglect during childhood is associated with particularly severe and persistent deleterious outcomes. Amygdala hyperreactivity has been observed in childhood trauma survivors and implicated in symptoms of PTSD. Objective: The neuropeptide oxytocin holds promise as a potential treatment for PTSD due to its ability to attenuate amygdala response to threat cues. However, the effect of oxytocin on amygdala reactivity in individuals with childhood trauma-related PTSD has not been investigated. Method: We employed a double-blind, randomized, placebo-controlled crossover design to examine the effects of intranasal oxytocin (24 IU) versus placebo on amygdala reactivity to fearful faces among childhood-trauma exposed individuals with PTSD (n = 17) and without PTSD (control group; n = 16). Results: Region-of-interest based amygdala fMRI signal magnitude did not differ by group, drug, or group x drug interaction. Self-report of childhood trauma exposure severity was negatively associated with the oxytocin-related change in left amygdala response in the PTSD group, but not in the control group. Supplementary and exploratory whole-brain analyses conducted separately in each group revealed that left amygdala reactivity to fearful faces was absent on placebo but increased on oxytocin in the control group. The PTSD group showed right amygdala activation to fearful faces in both the oxytocin and placebo conditions, but the left amygdala response observed in the placebo condition was diminished on oxytocin. Conclusions: Findings extend the literature pertaining to the potential for oxytocin to attenuate neural correlates of PTSD to a childhood trauma-related PTSD sample. * We examined intranasal oxytocin effects on amygdala reactivity to fearful faces.* Participants were childhood trauma-exposed individuals with PTSD compared to resilient controls.* No group, drug, or group x drug interaction effects emerged.* In PTSD, more severe childhood trauma predicted greater amygdala change under oxytocin.
ISSN:2000-8066
2000-8198
2000-8066
DOI:10.1080/20008198.2019.1606626